Search All News
Natasha Kulviwat, a rising high school senior, discovered a protein that may serve as predictor for suicide and could potentially lead to new strategies for intervention and prevention.
Opening remarks were delivered by Dr. Blair Simpson, interim chair of psychiatry at Columbia.
- May 26, 2021
Columbia study also finds people with schizophrenia, overall, have a 4.5-fold increased risk of dying from suicide.
- May 24, 2021
A Columbia study looked at a short and promising approach that could encourage more health workers to get the mental health care they need via a method centered on a three-minute video.
Source:Medpage TodayFebruary 24, 2021
Dr. Jeffrey Lieberman and co-authors hypothesized that combining the xanomeline with trospium could lessen xanomeline's typical side effects in treating schizophrenia.
- February 18, 2021
Columbia researchers have published their first report on mass shootings from the Columbia Mass Murder Database (CMMD).
- November 16, 2020
The Substance Abuse and Mental Health Services Administration has awarded $32 million to the American Academy of Addiction Psychiatry to address opioid use disorders and stimulant use disorders.
Source:BusinesswireNovember 16, 2020
“The COVID-19 pandemic will be accompanied by a wave of mental health consequences for children, adolescents, and families,” said Dr. Jeremy Veenstra-VanderWeele.
- November 9, 2020
Columbia researchers have found a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation
Source:MedscapeOctober 26, 2020
Dr. J. John Mann joins Dr. Lloyd Sederer on Medscape to discuss the effectiveness of Ketamine as a treatment for depression.